Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and 18 F-FDG PET

Radiology
Isabelle RiedererStefan Förster

Abstract

Purpose To compare PET/MR hypoperfusion and hypometabolism in patients with Alzheimer disease (AD) and mild cognitive impairment (MCI) compared with healthy control (HC) participants. Materials and Methods Maps of cerebral blood flow (CBF; pulsed arterial spin-labeling [ASL] MRI), glucose metabolism (fluorine 18 [18F] fluorodeoxyglucose [FDG] PET), and gray matter (GM) volume (structural T1-weighted MRI) were calculated from integrated PET/MR data in 45 patients with AD (mean age, 69 years ± 9 [standard deviation]; age range, 51-89 years), 20 patients with MCI (mean age, 64 years ± 10; age range, 45-82 years), and 11 HC participants (mean age, 65 years ± 8; age range, 54-80 years) between 2011 and 2014. After preprocessing, voxel-wise analyses of variance, volume of interest, and independent component analyses were performed for comparisons of CBF and glucose metabolism. Results Analyses revealed high overlap between components, regional and quantitative hypoperfusion, and hypometabolism in patients with AD compared with HC participants in precuneus, parietal, temporal, and occipital cortex. In patients with MCI compared with HC participants, FDG PET exclusively demonstrated quantitative hypometabolism and a component in the pr...Continue Reading

References

Jan 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D S WilliamsA P Koretsky
Jan 1, 1995·Alzheimer Disease and Associated Disorders·K Herholz
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·M J de LeonJ Fowler
Nov 22, 2001·JAMA : the Journal of the American Medical Association·D H SilvermanM E Phelps
May 30, 2006·The Journal of Experimental Biology·Pierre J Magistretti
Jan 22, 2008·CNS Spectrums·Ronald C Petersen, Selamawit Negash
Dec 17, 2009·Neurobiology of Aging·Luiz K FerreiraMarcus V Zanetti
Nov 12, 2010·Nature·David AttwellEric A Newman
Jul 26, 2011·European Archives of Psychiatry and Clinical Neuroscience·Panagiotis AlexopoulosChristine Preibisch
Sep 29, 2011·Journal of Magnetic Resonance Imaging : JMRI·Christine PreibischPanagiotis Alexopoulos
Oct 25, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Erik S MusiekJohn A Detre
Jan 19, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Anna DevorDavid A Boas
Apr 19, 2012·NeuroImage·Paule-Joanne ToussaintUNKNOWN Benali, for the Alzheimer's Disease Neuroimaging Initiative
Dec 13, 2012·Radiology·Jennifer L ShafferUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Apr 19, 2013·Frontiers in Cellular Neuroscience·Jillian L Stobart, Christopher M Anderson
Apr 10, 2014·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·David C AlsopGreg Zaharchuk
May 3, 2014·Journal of Neuroscience Methods·Jiayu ChenJessica A Turner
Aug 8, 2015·Human Brain Mapping·Jiayu ChenJingyu Liu
Oct 7, 2015·Human Brain Mapping·Michel J GrotheUNKNOWN Alzheimer's Disease Neuroimaging Initiative
May 6, 2016·Frontiers in Neuroscience·Stefano TrebeschiAlexander Valentinitsch
Oct 7, 2016·Frontiers in Neurology·Jennifer Ashley CiarochiUNKNOWN PREDICT-HD Investigators and Coordinators of the Huntington Study Group
Mar 4, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Alexandre SavioIgor Yakushev

❮ Previous
Next ❯

Citations

Dec 4, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Yonglu ChenBiao Huang
Jan 22, 2020·European Journal of Nuclear Medicine and Molecular Imaging·Jenny CeccariniKoen Van Laere
Mar 7, 2019·Frontiers in Aging Neuroscience·Merel van der ThielSven Haller
Oct 22, 2020·Journal of Neurology·Michael J FirbankAlan J Thomas
Jan 14, 2020·NeuroImage. Clinical·Sudipto DoluiDavid A Wolk
Feb 3, 2021·Seminars in Nuclear Medicine·Patrick Dupont
Nov 13, 2020·Behavioural Neurology·Bin ZhouThe Alzheimer's Disease Neuroimaging Initiative
Nov 2, 2021·ACS Chemical Neuroscience·Ying ZhouXiaoying Tang
Apr 27, 2020·NeuroImage·Mario E Archila-MeléndezChristine Preibisch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.